Review
Open access
Sep 2026
“Updates on diagnostic and prognostic molecular biomarkers of CNS tumors”
The diagnosis and classification of central nervous system (CNS) tumors has undergone a paradigm shift over the past decade, evolving from a purely histology-based approach to an integrated framework that incorporates molecular and epigenetic features. This review summarizes recent updates in key genomic and epigenomic...
Shane Eaton, Ahmad R. Almotairi, Adrian B. Levine et al.
· Neurotherapeutics · 0 citations